| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 359 | 2020 |
| Autochthonous Crimean–Congo Hemorrhagic Fever in Spain A Negredo, F de la Calle-Prieto, E Palencia-Herrejón, M Mora-Rillo, ... New England Journal of Medicine 377 (2), 154-161, 2017 | 209 | 2017 |
| Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years A Fernández-Cruz, P Muñoz, R Mohedano, M Valerio, M Marín, L Alcalá, ... Medicine 89 (5), 319-330, 2010 | 164 | 2010 |
| Dalbavancin in the treatment of different gram-positive infections: a real-life experience E Bouza, M Valerio, A Soriano, L Morata, EG Carus, ... International journal of antimicrobial agents 51 (4), 571-577, 2018 | 154 | 2018 |
| Convalescent plasma for COVID-19: a multicenter, randomized clinical trial C Avendano-Sola, A Ramos-Martinez, E Munez-Rubio, B Ruiz-Antoran, ... MedRxiv, 2020.08. 26.20182444, 2020 | 118 | 2020 |
| A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality A Fernández-Cruz, B Ruiz-Antorán, A Muñoz-Gómez, A Sancho-López, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 01168-20, 2020 | 115 | 2020 |
| The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia E Bouza, M Kestler, T Beca, G Mariscal, M Rodríguez-Créixems, ... Clinical Infectious Diseases 60 (4), 528-535, 2015 | 104 | 2015 |
| A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia C Avendaño-Solá, A Ramos-Martínez, E Muñez-Rubio, B Ruiz-Antorán, ... The Journal of Clinical Investigation 131 (20), 2021 | 96 | 2021 |
| Antifungal stewardship in a tertiary-care institution: a bedside intervention M Valerio, P Munoz, CG Rodriguez, B Caliz, B Padilla, A Fernandez-Cruz, ... Clinical Microbiology and Infection 21 (5), 492. e1-492. e9, 2015 | 87 | 2015 |
| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 77 | 2021 |
| WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for … M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, ... jama 326 (6), 499-518, 2021 | 67 | 2021 |
| The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort A Fernández-Cruz, M Cruz Menárguez, P Muñoz, M Pedromingo, ... European journal of clinical microbiology & infectious diseases 34, 1543-1549, 2015 | 66 | 2015 |
| Role of age and comorbidities in mortality of patients with infective endocarditis C Armiñanzas, C Fariñas-Alvarez, J Zarauza, P Muñoz, VG Ramallo, ... European Journal of Internal Medicine 64, 63-71, 2019 | 58 | 2019 |
| Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study B Ruiz-Antorán, A Sancho-López, F Torres, V Moreno-Torres, ... Infectious diseases and therapy 10, 347-362, 2021 | 57 | 2021 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 54 | 2023 |
| Infectious and non-infectious neurologic complications in heart transplant recipients P Muñoz, M Valerio, J Palomo, J Fernández-Yáñez, A Fernández-Cruz, ... Medicine 89 (3), 166-175, 2010 | 53 | 2010 |
| Gram-negative bloodstream infections P Muñoz, AF Cruz, M Rodríguez-Créixems, E Bouza International journal of antimicrobial agents 32, S10-S14, 2008 | 53 | 2008 |
| The value of combining blood culture and SeptiFast data for predicting complicated bloodstream infections caused by Gram-positive bacteria or Candida species A Fernández-Cruz, M Marín, M Kestler, L Alcalá, M Rodriguez-Créixems, ... Journal of clinical microbiology 51 (4), 1130-1136, 2013 | 50 | 2013 |
| Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: a retrospective controlled cohort study A Fernández Cruz, B Ruiz-Antoran, AM Gómez, A Sancho López, ... medRxiv, 2020.05. 22.20110544, 2020 | 49 | 2020 |
